论文信息 - Phase-I study of α-1,3,5-Triglycidyl-s-triazinetrione (NSC 296934) - 字舞流文

Phase-I study of α-1,3,5-Triglycidyl-s-triazinetrione (NSC 296934)

H. Hansen | P. Dombernowsky | B. Lund

[1] M. Piccart,et al. Phase I clinical trial with alpha 1,3,5- triglycidyl-s-triazinetrione (NSC-296934). , 1981, European journal of cancer & clinical oncology.

[2] P. Dumont,et al. Antitumoral effect in mice of a new triepoxyde derivative: 1, 3, 5-triglycidyl-s-triazinetrione (NSC 296934). , 1980, European journal of cancer.

[3] M. Budnowski. Herstellung und Eigenschaften der diastereomeren Triglycidylisocyanurate , 1968 .

[4] E J Freireich,et al. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. , 1966, Cancer chemotherapy reports.

[5] G. Atassi,et al. A characterization of the activity of α-1,3,5-triglycidyl-s-triazinetrione, a novel antineoplastic compound , 2004, Cancer Chemotherapy and Pharmacology.

[6] R. D. Hunter,et al. WHO Handbook for Reporting Results of Cancer Treatment , 1980 .